Antitrust Group Backs Cipro Buyers In Pay-For-Delay Row

Law360, New York (March 18, 2014, 8:19 PM EDT) -- The American Antitrust Institute and a group of nearly 50 professors on Tuesday urged California's highest court to revive a pay-for-delay antitrust case over the drug Cipro, arguing that a lower court’s dismissal of the putative class action cannot stand in the wake of a recent U.S. Supreme Court ruling.

In two separate amicus briefs, the AIA and a group of 49 antitrust and intellectual property professors argued that a California state court’s dismissal of a suit accusing Bayer AG and several generic drugmakers of illegally...
To view the full article, register now.